Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-22-019753

Director bought 317,460 shares at $3.15 ($999,999)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hamilton Thomas Edward Director 2022-09-16 Purchase +317,460 $3.15 $999,999 507,590 D: show line 1 in the form
Open-market purchases · 317,460 sh · avg $3.15 · $999,999
Loading xslF345X03/form4.xml…